October 16, 2026 05:12 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot | Netflix scores big FIFA deal: All 104 World Cup 2030 matches to stream live in Spain, Andorra | Jantar Mantar crackdown: CJP's Saurav Das, Ashutosh Ranka sent to jail for 5 days
Delta variant
Image Credit: Unsplash

Delta variant of Covid can infect even after Covishield, Covaxin jabs: AIIMS study

| @indiablooms | Jun 09, 2021, at 10:19 pm

New Delhi/IBNS: The 'delta' variant of COVID-19, the version first detected in India in October last year, can infect people even after they have received both jabs of the Covaxin or Covishield vaccines, new studies, done separately by AIIMS (Delhi) and the National Centre for Disease Control (NCDC), revealed.

It should be mentioned that neither of the studies has been peer-reviewed till now.

As per the AIIMS study, the Delta variant is the reason behind the overwhelming cases in India.

According to British health authorities, this variant is between 40 and 50 per cent more infectious than the 'alpha' version first reported from the UK.

The AIIMS-IGIB (Institute of Genomics and Integrative Biology) study was based on an analysis of 63 symptomatic patients who reported to the hospital's emergency ward complaining of high fever persisting for five to seven days.

Of these 63 people, 53 had been administered at least one dose of Covaxin and the rest at least one dose of Covishield. Thirty-six of them had received both doses of one of these vaccines.

76.9 per cent of infections by the 'delta' variant were recorded in people who had received a single dose, and 60 per cent in people who had received both doses.

Meanwhile, data from the NCDC-IGIB study indicated that breakthrough infections due to the 'delta' variant of Covid seemed to affect people who took Covishield.

This study revealed 'delta' breakthrough infections in 27 patients who had taken Covishiled, with the infection rate at 70.3 per cent.

In fact, data from both studies indicated the 'alpha' variant is also proving resistant to Covishield and Covaxin, but not as significant as the version first reported from India.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.